Ferraz Rodrigo Branco, Gualano Bruno, Filho Carlos Merege, Almeida Murilo Groschitz, Perandini Luiz Augusto, Dassouki Thalita, Sá-Pinto Ana Lúcia, Lima Fernanda Rodrigues, Roschel Hamilton
Division of Rheumatology, Faculty of Medicine, School of Medicine, University of São Paulo, Av. Dr. Arnaldo, 455 - 3° andar - sala 3131 - Cerqueira César, São Paulo, 05403-000, Brazil.
Rheumatol Int. 2015 Jun;35(6):1027-36. doi: 10.1007/s00296-014-3169-x. Epub 2014 Nov 6.
The purpose of the study was to report on the safety and feasibility of the application of maximal physical tests in a heterogeneous cohort of rheumatic patients. This is a 5-year retrospective descriptive report on the incidence of events associated with maximal physical testing from 536 patients, totalizing 5,910 tests. Tests were classified as cardiopulmonary, muscle strength, and physical functioning tests. Any adverse events during the tests and limiting factors incurring in tests cancellation were reported. Eighteen out of 641 cardiopulmonary exercise tests had an adverse occurrence, with cardiac disturbance (1.4% of total tests) being the most prevalent. Moreover, 14 out of 641 tests were not feasible. Out of 3,478 tests comprising leg press, bench press, knee extension, and handgrip tests, 15 tests had an adverse event. The most common occurrence was joint pain (0.4% of total tests), which was also the most frequent factor precluding testing (0.5% of total tests). Forty-five out of 3,478 (1.3%) of the tests were not feasible. There was a very low incidence of events (0.2%) during the physical functioning tests. Joint pain was the only adverse event during the tests, whereas physical limitations were the most important barriers for the execution of the tests (1.1% of total tests). The incidence of limiting events in this test was 1.6% (n = 29). This report brings new data on the safety and feasibility of maximal physical testing in rheumatic patients. The physical tests described in this study may be applied for testing rheumatic patients both in research and clinical setting.
本研究的目的是报告在一组异质性风湿性疾病患者中进行最大体能测试的安全性和可行性。这是一项为期5年的回顾性描述性报告，涉及536例患者共5910次最大体能测试相关事件的发生率。测试分为心肺功能测试、肌肉力量测试和身体功能测试。报告了测试期间的任何不良事件以及导致测试取消的限制因素。641次心肺运动测试中有18次出现不良事件，其中心脏不适（占总测试次数的1.4%）最为常见。此外，641次测试中有14次不可行。在包括腿举、卧推、膝关节伸展和握力测试在内的3478次测试中，有15次出现不良事件。最常见的是关节疼痛（占总测试次数的0.4%），这也是导致测试无法进行的最常见因素（占总测试次数的0.5%）。3478次测试中有45次（1.3%）不可行。身体功能测试期间的事件发生率非常低（0.2%）。关节疼痛是测试期间唯一的不良事件，而身体限制是测试执行的最重要障碍（占总测试次数的1.1%）。该测试中限制事件的发生率为1.6%（n = 29）。本报告提供了关于风湿性疾病患者最大体能测试安全性和可行性的新数据。本研究中描述的体能测试可用于风湿性疾病患者在研究和临床环境中的测试。
